Tissue Engineering

Biologically Produced Vessels Meet Grafting Requirements

Published in Blood Weekly, April 13th, 1998

It may be possible to produce blood vessels exclusively from human cells.

The production of tissue-engineered blood vessels (TEBVs) has required synthetic or modified biological materials for structural support.

Nicholas L'Heureux, Hopital du Saint-Sacrement, Quebec, Canada, and colleagues reported a novel approach to TEBV production which uses no synthetic or exogenous biomaterials, but rather is based solely on the use of cultured cells ("A Completely Biological Tissue-Engineered Human Blood Vessel," FASEB Journal, 1998;12:47-56).

L'Heureux et al. said their results suggest that their technique can produce completely biological...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1998-04-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry